CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 96 filers reported holding CARDIFF ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,074,416 | +767340.0% | 651,161 | +651061.0% | 0.00% | – |
Q4 2022 | $140 | -86.0% | 100 | -73.6% | 0.00% | – |
Q2 2022 | $1,000 | -80.0% | 379 | -79.4% | 0.00% | – |
Q1 2022 | $5,000 | -92.2% | 1,837 | -82.6% | 0.00% | – |
Q4 2021 | $64,000 | +88.2% | 10,574 | +105.1% | 0.00% | – |
Q3 2021 | $34,000 | +30.8% | 5,155 | +32.8% | 0.00% | – |
Q2 2021 | $26,000 | -87.2% | 3,883 | -82.2% | 0.00% | – |
Q1 2021 | $203,000 | -52.8% | 21,873 | -8.6% | 0.00% | – |
Q4 2020 | $430,000 | – | 23,928 | +199300.0% | 0.00% | – |
Q3 2020 | $0 | – | 12 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |